Old | New | Differences | |
---|---|---|---|
1 | - | WES MOORE, Governor Ch. 752 | |
2 | 1 | ||
3 | - | – 1 – | |
4 | - | Chapter 752 | |
5 | - | (House Bill 119) | |
6 | 2 | ||
7 | - | AN ACT concerning | |
3 | + | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | + | [Brackets] indicate matter deleted from existing law. | |
5 | + | Underlining indicates amendments to bill. | |
6 | + | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | + | amendment. | |
8 | + | Italics indicate opposite chamber/conference committee amendments. | |
9 | + | *hb0119* | |
8 | 10 | ||
9 | - | Public Health – Giving Infants a Future Without Transmission (GIFT) Act | |
11 | + | HOUSE BILL 119 | |
12 | + | J1 (4lr0158) | |
13 | + | ENROLLED BILL | |
14 | + | — Health and Government Operations/Finance — | |
15 | + | Introduced by Chair, Health and Government Operations Committee (By Request | |
16 | + | – Departmental – Health) | |
10 | 17 | ||
11 | - | FOR the purpose of altering certain HIV and syphilis reporting and testing requirements | |
12 | - | for hospitals and health care providers for pregnant women and newborns, including | |
13 | - | by requiring that the pregnancy status of certain individuals be included in certain | |
14 | - | reports and that certain health care providers submit certain blood samples to | |
15 | - | medical laboratories; providing that certain documents related to certain HIV and | |
16 | - | syphilis reports are not discoverable and are not admissible in evidence in any | |
17 | - | criminal or administrative action; altering certain penalties related to the disclosure | |
18 | - | of personal identifying health information acquired for the purpose of HIV and AIDS | |
19 | - | reporting under certain provisions of law; and generally relating to testing and | |
20 | - | reporting requirements for HIV and syphilis. | |
18 | + | Read and Examined by Proofreaders: | |
21 | 19 | ||
22 | - | BY repealing and reenacting, with amendments, | |
23 | - | Article – Health – General | |
24 | - | Section 18–201.1, 18–202.1, 18–215(e), 18–307, and 18–336 | |
25 | - | Annotated Code of Maryland | |
26 | - | (2023 Replacement Volume) | |
20 | + | _______________________________________________ | |
21 | + | Proofreader. | |
22 | + | _______________________________________________ | |
23 | + | Proofreader. | |
27 | 24 | ||
28 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, | |
29 | - | That the Laws of Maryland read as follows: | |
25 | + | Sealed with the Great Seal and presented to the Governor, for his appr oval this | |
30 | 26 | ||
31 | - | ||
27 | + | _______ day of _______________ at ________________________ o’clock, ________M. | |
32 | 28 | ||
33 | - | 18–201.1. | |
29 | + | ______________________________________________ | |
30 | + | Speaker. | |
34 | 31 | ||
35 | - | (a) A [physician] HEALTH CARE PROVIDER who has diagnosed [a patient] AN | |
36 | - | INDIVIDUAL under the [physician’s] HEALTH CARE PROVIDER ’S care with [human | |
37 | - | immunodeficiency virus] HIV infection or acquired immunodeficiency syndrome according | |
38 | - | to the current definition published in the [morbidity and mortality weekly report] | |
39 | - | MORBIDITY AND MORTALITY WEEKLY REPORT by the Centers for Disease Control and | |
40 | - | Prevention of the Department of Health and Human Services shall submit immediately a | |
41 | - | report to the health officer for the county where the [physician] HEALTH CARE PROVIDER | |
42 | - | cares for that [patient] INDIVIDUAL. | |
32 | + | CHAPTER ______ | |
43 | 33 | ||
44 | - | ||
34 | + | AN ACT concerning 1 | |
45 | 35 | ||
46 | - | ( | |
36 | + | Public Health – Giving Infants a Future Without Transmission (GIFT) Act 2 | |
47 | 37 | ||
48 | - | (2) Identify the disease; Ch. 752 2024 LAWS OF MARYLAND | |
38 | + | FOR the purpose of altering certain HIV and syphilis reporting and testing requirements 3 | |
39 | + | for hospitals and health care providers for pregnant women and newborns, including 4 | |
40 | + | by requiring that the pregnancy status of certain individuals be included in certain 5 | |
41 | + | reports and that certain health care providers submit certain blood samples to 6 | |
42 | + | medical laboratories; providing that certain documents related to certain HIV and 7 | |
43 | + | syphilis reports are not discoverable and are not admissible in evidence in any 8 | |
44 | + | criminal or administrative action; altering certain penalties related to the disclosure 9 | |
45 | + | of personal identifying health information acquired for the purpose of HIV and AIDS 10 | |
46 | + | reporting under certain provisions of law; and generally relating to testing and 11 | |
47 | + | reporting requirements for HIV and syphilis. 12 | |
49 | 48 | ||
50 | - | ||
49 | + | BY repealing and reenacting, with amendments, 13 2 HOUSE BILL 119 | |
51 | 50 | ||
52 | - | (3) State the name, age, race, sex, and residence address of the [patient; | |
53 | - | and] INDIVIDUAL; | |
54 | 51 | ||
55 | - | (4) STATE THE PREGNANCY STATUS OF THE INDIVI DUAL, IF | |
56 | - | APPLICABLE; AND | |
52 | + | Article – Health – General 1 | |
53 | + | Section 18–201.1, 18–202.1, 18–215(e), 18–307, and 18–336 2 | |
54 | + | Annotated Code of Maryland 3 | |
55 | + | (2023 Replacement Volume) 4 | |
57 | 56 | ||
58 | - | [(4)] (5) Be signed by the [physician] HEALTH CARE PROVIDER . | |
57 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 5 | |
58 | + | That the Laws of Maryland read as follows: 6 | |
59 | 59 | ||
60 | - | (c) (1) A [physician] HEALTH CARE PROVIDER shall submit a report as | |
61 | - | described in subsection (b) of this section to the Secretary within 48 hours of [the]: | |
60 | + | Article – Health – General 7 | |
62 | 61 | ||
63 | - | (I) THE birth of an infant whose mother has tested positive for [the | |
64 | - | human immunodeficiency virus] HIV; AND | |
62 | + | 18–201.1. 8 | |
65 | 63 | ||
66 | - | (II) A PREGNANT WOMAN TESTING POSITIVE FOR HIV, FOR THE | |
67 | - | PURPOSE OF INTERVENT ION. | |
64 | + | (a) A [physician] HEALTH CARE PROVIDER who has diagnosed [a patient] AN 9 | |
65 | + | INDIVIDUAL under the [physician’s] HEALTH CARE PROVIDER ’S care with [human 10 | |
66 | + | immunodeficiency virus] HIV infection or acquired immunodeficiency syndrome according 11 | |
67 | + | to the current definition published in the [morbidity and mortality weekly report] 12 | |
68 | + | MORBIDITY AND MORTALITY WEEKLY REPORT by the Centers for Disease Control and 13 | |
69 | + | Prevention of the Department of Health and Human Services shall submit immediately a 14 | |
70 | + | report to the health officer for the county where the [physician] HEALTH CARE PROVIDER 15 | |
71 | + | cares for that [patient] INDIVIDUAL. 16 | |
68 | 72 | ||
69 | - | (2) If a newborn infant does not become HIV positive after 18 months from | |
70 | - | the [date that the report required in paragraph (1) of this subsection was submitted] | |
71 | - | INFANT’S DATE OF BIRTH , the Secretary shall have the newborn infant’s name removed | |
72 | - | from the HIV registry. | |
73 | + | (b) The report shall: 17 | |
73 | 74 | ||
74 | - | (d) (1) All [physician] HEALTH CARE PROVIDER reports required under this | |
75 | - | section are: | |
75 | + | (1) Be on the form that the Secretary provides; 18 | |
76 | 76 | ||
77 | - | ( | |
77 | + | (2) Identify the disease; 19 | |
78 | 78 | ||
79 | - | ( | |
80 | - | ||
79 | + | (3) State the name, age, race, sex, and residence address of the [patient; 20 | |
80 | + | and] INDIVIDUAL; 21 | |
81 | 81 | ||
82 | - | (2) The reports and any proceedings, records, or files relating to the reports | |
83 | - | required under this section are not discoverable and are not admissible in evidence in any | |
84 | - | civil action CRIMINAL, CIVIL, OR ADMINISTRATIVE AC TION. | |
82 | + | (4) STATE THE PREGNANCY S TATUS OF THE INDIVIDUAL, IF 22 | |
83 | + | APPLICABLE; AND 23 | |
85 | 84 | ||
86 | - | (3) This subsection does not apply to a disclosure by the Secretary to | |
87 | - | another governmental agency performing its lawful duties pursuant to State or federal law | |
88 | - | where the Secretary determines the agency to whom the information is disclosed will | |
89 | - | maintain the confidentiality of the disclosure. | |
85 | + | [(4)] (5) Be signed by the [physician] HEALTH CARE PROVIDER . 24 | |
90 | 86 | ||
91 | - | 18–202.1. | |
87 | + | (c) (1) A [physician] HEALTH CARE PROVIDER shall submit a report as 25 | |
88 | + | described in subsection (b) of this section to the Secretary within 48 hours of [the]: 26 | |
92 | 89 | ||
93 | - | (a) In this section, “institution” includes: | |
90 | + | (I) THE birth of an infant whose mother has tested positive for [the 27 | |
91 | + | human immunodeficiency virus] HIV; AND 28 | |
94 | 92 | ||
95 | - | (1) A hospital; WES MOORE, Governor Ch. 752 | |
93 | + | (II) A PREGNANT WOMAN TESTI NG POSITIVE FOR HIV, FOR THE 29 | |
94 | + | PURPOSE OF INTERVENT ION. 30 | |
95 | + | HOUSE BILL 119 3 | |
96 | 96 | ||
97 | - | – 3 – | |
98 | 97 | ||
99 | - | (2) A nursing home; | |
98 | + | (2) If a newborn infant does not become HIV positive after 18 months from 1 | |
99 | + | the [date that the report required in paragraph (1) of this subsection was submitted] 2 | |
100 | + | INFANT’S DATE OF BIRTH , the Secretary shall have the newborn infant’s name removed 3 | |
101 | + | from the HIV registry. 4 | |
100 | 102 | ||
101 | - | (3) A hospice facility; | |
103 | + | (d) (1) All [physician] HEALTH CARE PROVIDER reports required under this 5 | |
104 | + | section are: 6 | |
102 | 105 | ||
103 | - | ( | |
106 | + | (i) Confidential and subject to Title 4, Subtitle 1 of this article; and 7 | |
104 | 107 | ||
105 | - | (5) An inpatient psychiatric facility; and | |
108 | + | (ii) Not medical records under Title 4, Subtitle 3 of this article, but 8 | |
109 | + | are subject to the confidentiality requirements of Title 4, Subtitle 1 of this article. 9 | |
106 | 110 | ||
107 | - | (6) An inpatient drug rehabilitation facility. | |
111 | + | (2) The reports and any proceedings, records, or files relating to the reports 10 | |
112 | + | required under this section are not discoverable and are not admissible in evidence in any 11 | |
113 | + | civil action CRIMINAL, CIVIL, OR ADMINISTRATIVE AC TION. 12 | |
108 | 114 | ||
109 | - | (b) When an institution has an individual in the care of the institution with a | |
110 | - | diagnosis of [human immunodeficiency virus] HIV or acquired immunodeficiency | |
111 | - | syndrome according to the current definition published in the [morbidity and mortality | |
112 | - | weekly report] MORBIDITY AND MORTALITY WEEKLY REPORT by the Centers for | |
113 | - | Disease Control and Prevention, a clinical or infection control practitioner shall submit a | |
114 | - | report within 48 hours to the health officer for the county where the institution is located. | |
115 | + | (3) This subsection does not apply to a disclosure by the Secretary to 13 | |
116 | + | another governmental agency performing its lawful duties pursuant to State or federal law 14 | |
117 | + | where the Secretary determines the agency to whom the information is disclosed will 15 | |
118 | + | maintain the confidentiality of the disclosure. 16 | |
115 | 119 | ||
116 | - | ||
120 | + | 18–202.1. 17 | |
117 | 121 | ||
118 | - | ( | |
122 | + | (a) In this section, “institution” includes: 18 | |
119 | 123 | ||
120 | - | ( | |
124 | + | (1) A hospital; 19 | |
121 | 125 | ||
122 | - | (3) State the name, age, race, sex, and residence address of the individual | |
123 | - | with the disease; | |
126 | + | (2) A nursing home; 20 | |
124 | 127 | ||
125 | - | (4) STATE THE PREGNANCY S TATUS OF THE INDIVID UAL, IF | |
126 | - | APPLICABLE; | |
128 | + | (3) A hospice facility; 21 | |
127 | 129 | ||
128 | - | | |
130 | + | (4) A medical clinic in a correctional facility; 22 | |
129 | 131 | ||
130 | - | | |
132 | + | (5) An inpatient psychiatric facility; and 23 | |
131 | 133 | ||
132 | - | ( | |
134 | + | (6) An inpatient drug rehabilitation facility. 24 | |
133 | 135 | ||
134 | - | (i) Confidential and subject to Title 4, Subtitle 1 of this article; and | |
136 | + | (b) When an institution has an individual in the care of the institution with a 25 | |
137 | + | diagnosis of [human immunodeficiency virus] HIV or acquired immunodeficiency 26 | |
138 | + | syndrome according to the current definition published in the [morbidity and mortality 27 | |
139 | + | weekly report] MORBIDITY AND MORTALITY WEEKLY REPORT by the Centers for 28 | |
140 | + | Disease Control and Prevention, a clinical or infection control practitioner shall submit a 29 | |
141 | + | report within 48 hours to the health officer for the county where the institution is located. 30 | |
135 | 142 | ||
136 | - | (ii) Not medical records under Title 4, Subtitle 3 of this article, but | |
137 | - | are subject to the confidentiality requirements of Title 4, Subtitle 1 of this article. | |
143 | + | (c) The report shall: 31 4 HOUSE BILL 119 | |
138 | 144 | ||
139 | - | (2) The reports and any proceedings, records, or files relating to the reports | |
140 | - | required under this section are not discoverable and are not admissible in evidence in any | |
141 | - | civil action CRIMINAL, CIVIL, OR ADMINISTRATIVE AC TION. | |
142 | - | Ch. 752 2024 LAWS OF MARYLAND | |
143 | 145 | ||
144 | - | – 4 – | |
145 | - | (3) This subsection does not apply to a disclosure by the Secretary to | |
146 | - | another governmental agency performing its lawful duties in accordance with State or | |
147 | - | federal law where the Secretary determines the agency to whom the information is | |
148 | - | disclosed will maintain the confidentiality of the disclosure. | |
149 | 146 | ||
150 | - | ||
147 | + | (1) Be on the form that the Secretary provides; 1 | |
151 | 148 | ||
152 | - | (e) A health care provider or any other person, including an officer or employee of | |
153 | - | a governmental unit, who knowingly and willfully discloses personal identifying health | |
154 | - | information acquired for the purposes of HIV and AIDS reporting under § 18–201.1, § | |
155 | - | 18–202.1, § 18–205, or § 18–207 of this subtitle to any person who is not authorized to receive | |
156 | - | personal identifying health information under this subtitle or otherwise in violation of this | |
157 | - | subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding | |
158 | - | [$1,000] $2,000 for the first offense and not exceeding [$5,000] $10,000 for each | |
159 | - | subsequent conviction for a violation of any provision of this subtitle. | |
149 | + | (2) Identify the disease; 2 | |
160 | 150 | ||
161 | - | 18–307. | |
151 | + | (3) State the name, age, race, sex, and residence address of the individual 3 | |
152 | + | with the disease; 4 | |
162 | 153 | ||
163 | - | ( | |
164 | - | ||
154 | + | (4) STATE THE PREGNANCY S TATUS OF THE INDIVID UAL, IF 5 | |
155 | + | APPLICABLE; 6 | |
165 | 156 | ||
166 | - | (b) (1) The [individual] HEALTH CARE PROVIDER attending a woman for | |
167 | - | pregnancy shall submit to a medical laboratory: | |
157 | + | [(4)] (5) State the name of the administrative head of the institution; and 7 | |
168 | 158 | ||
169 | - | (i) A blood sample taken from the woman at the time that the | |
170 | - | [individual] HEALTH CARE PROVIDER first examines the woman; [and] | |
159 | + | [(5)] (6) State the address of the institution. 8 | |
171 | 160 | ||
172 | - | (ii) A blood sample taken from the woman [during the third | |
173 | - | trimester of the pregnancy] IN THE THIRD TRIMEST ER AT: | |
161 | + | (d) (1) All institution reports required under this section are: 9 | |
174 | 162 | ||
175 | - | 1 | |
163 | + | (i) Confidential and subject to Title 4, Subtitle 1 of this article; and 10 | |
176 | 164 | ||
177 | - | | |
178 | - | ||
165 | + | (ii) Not medical records under Title 4, Subtitle 3 of this article, but 11 | |
166 | + | are subject to the confidentiality requirements of Title 4, Subtitle 1 of this article. 12 | |
179 | 167 | ||
180 | - | (III) 1. A BLOOD SAMPLE TAKEN F ROM THE WOMAN WHO | |
181 | - | DELIVERS A LIVE BORN INFANT AT THE TIME O F DELIVERY; OR | |
168 | + | (2) The reports and any proceedings, records, or files relating to the reports 13 | |
169 | + | required under this section are not discoverable and are not admissible in evidence in any 14 | |
170 | + | civil action CRIMINAL, CIVIL, OR ADMINISTRATIVE AC TION. 15 | |
182 | 171 | ||
183 | - | 2. A BLOOD SAMPLE TAKEN F ROM THE W OMAN WHO | |
184 | - | DELIVERS A STILLBORN INFANT: | |
172 | + | (3) This subsection does not apply to a disclosure by the Secretary to 16 | |
173 | + | another governmental agency performing its lawful duties in accordance with State or 17 | |
174 | + | federal law where the Secretary determines the agency to whom the information is 18 | |
175 | + | disclosed will maintain the confidentiality of the disclosure. 19 | |
185 | 176 | ||
186 | - | ||
177 | + | 18–215. 20 | |
187 | 178 | ||
188 | - | B. WEIGHING AT LEAST 500 GRAMS. | |
189 | - | WES MOORE, Governor Ch. 752 | |
179 | + | (e) A health care provider or any other person, including an officer or employee of 21 | |
180 | + | a governmental unit, who knowingly and willfully discloses personal identifying health 22 | |
181 | + | information acquired for the purposes of HIV and AIDS reporting under § 18–201.1, § 23 | |
182 | + | 18–202.1, § 18–205, or § 18–207 of this subtitle to any person who is not authorized to receive 24 | |
183 | + | personal identifying health information under this subtitle or otherwise in violation of this 25 | |
184 | + | subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding 26 | |
185 | + | [$1,000] $2,000 for the first offense and not exceeding [$5,000] $10,000 for each 27 | |
186 | + | subsequent conviction for a violation of any provision of this subtitle. 28 | |
190 | 187 | ||
191 | - | – 5 – | |
192 | - | (2) The medical laboratory to which a blood sample is submitted shall do a | |
193 | - | standard serological syphilis test that is approved by the Department. | |
188 | + | 18–307. 29 | |
194 | 189 | ||
195 | - | (C) A HOSPITAL SHALL DETER MINE THE SYPHILIS SE ROLOGIC STATUS OF | |
196 | - | THE MOTHER BEFORE DI SCHARGING THE NEWBOR N FOR THE PURPOSES O F | |
197 | - | NEONATAL EVALUATION AND TREATMENT . | |
190 | + | (a) This section does not apply to a woman who objects to a standard serological 30 | |
191 | + | syphilis test because the test is against the religious beliefs and practices of the woman. 31 HOUSE BILL 119 5 | |
198 | 192 | ||
199 | - | (D) THE DEPARTMENT MAY ADOPT RULES, REGULATIONS , AND STANDARDS | |
200 | - | UNDER THIS SECTION. | |
201 | 193 | ||
202 | - | 18–336. | |
203 | 194 | ||
204 | - | (a) (1) In this section the following words have the meanings indicated. | |
195 | + | (b) (1) The [individual] HEALTH CARE PROVIDER attending a woman for 1 | |
196 | + | pregnancy shall submit to a medical laboratory: 2 | |
205 | 197 | ||
206 | - | ( | |
207 | - | ||
198 | + | (i) A blood sample taken from the woman at the time that the 3 | |
199 | + | [individual] HEALTH CARE PROVIDER first examines the woman; [and] 4 | |
208 | 200 | ||
209 | - | ( | |
210 | - | ||
201 | + | (ii) A blood sample taken from the woman [during the third 5 | |
202 | + | trimester of the pregnancy] IN THE THIRD TRIMEST ER AT: 6 | |
211 | 203 | ||
212 | - | (4) “HIV” means the human immunodeficiency virus that causes acquired | |
213 | - | immune deficiency syndrome. | |
204 | + | 1. THE PRENATAL VISIT AT 28 WEEKS OF GESTATION ; OR 7 | |
214 | 205 | ||
215 | - | (b) (1) Except as provided in Title 11, Subtitle 1, Part II of the Criminal | |
216 | - | Procedure Article or § 18–338.3 of this subtitle, before obtaining a fluid or tissue sample | |
217 | - | from the body of an individual for the purpose of testing the fluid or tissue for the presence | |
218 | - | of HIV infection, a health care provider shall: | |
206 | + | 2. THE FIRST PRENATAL VI SIT AFTER 28 WEEKS OF 8 | |
207 | + | GESTATION; AND 9 | |
219 | 208 | ||
220 | - | (i) Inform the individual verbally or in writing that HIV testing will | |
221 | - | be performed on a specimen obtained from the individual unless the individual refuses HIV | |
222 | - | testing; | |
209 | + | (III) 1. A BLOOD SAMPLE TAKEN F ROM THE WOMAN WHO 10 | |
210 | + | DELIVERS A LIVE BORN INFANT AT THE TIME O F DELIVERY; OR 11 | |
223 | 211 | ||
224 | - | (ii) Provide the individual verbal or written information or show a | |
225 | - | video that includes an explanation of HIV infection and the meaning of positive and | |
226 | - | negative test results; | |
212 | + | 2. A BLOOD SAMPLE TAKEN F ROM THE W OMAN WHO 12 | |
213 | + | DELIVERS A STILLBORN INFANT: 13 | |
227 | 214 | ||
228 | - | (iii) Offer the individual an opportunity to ask questions and decline | |
229 | - | HIV testing; and | |
215 | + | A. AT 20 WEEKS OF GESTATION O R LATER; OR 14 | |
230 | 216 | ||
231 | - | (iv) If the individual refuses HIV testing, document in the medical | |
232 | - | record the individual’s decision. | |
217 | + | B. WEIGHING AT LEAST 500 GRAMS. 15 | |
233 | 218 | ||
234 | - | (2) (i) Consent for HIV testing shall be included in a patient’s general | |
235 | - | informed consent for medical care in the same category as other screening and diagnostic | |
236 | - | tests. | |
237 | - | Ch. 752 2024 LAWS OF MARYLAND | |
219 | + | (2) The medical laboratory to which a blood sample is submitted shall do a 16 | |
220 | + | standard serological syphilis test that is approved by the Department. 17 | |
238 | 221 | ||
239 | - | – 6 – | |
240 | - | (ii) Except as otherwise provided in this section, a health care | |
241 | - | provider may not be required to obtain consent for HIV testing using a separate consent | |
242 | - | form. | |
222 | + | (C) A HOSPITAL SHALL DETER MINE THE SYPHILIS SE ROLOGIC STATUS OF 18 | |
223 | + | THE MOTHER BEFORE DI SCHARGING THE NEWBOR N FOR THE PURPOSES O F 19 | |
224 | + | NEONATAL EVALUATION AND TREATMENT . 20 | |
243 | 225 | ||
244 | - | (3) A health care provider shall make available to individuals for whom | |
245 | - | HIV testing is performed easily understood informational materials in the languages of the | |
246 | - | commonly encountered populations of the health care provider. | |
226 | + | (D) THE DEPARTMENT MAY ADOPT RULES, REGULATIONS , AND STANDARDS 21 | |
227 | + | UNDER THIS SECTION. 22 | |
247 | 228 | ||
248 | - | (C) UNLESS A PATIENT DECL INES SUBJECT TO SUBSECTION (B) OF THIS | |
249 | - | SECTION, A HEALTH CARE PROVID ER SHALL OBTAIN A FL UID OR TISSUE SAMPLE | |
250 | - | FOR THE PURPOSE OF T ESTING THE FLUID OR TISSUE FOR THE PRESE NCE OF HIV | |
251 | - | INFECTION FROM : | |
229 | + | 18–336. 23 | |
252 | 230 | ||
253 | - | (1) THE | |
231 | + | (a) (1) In this section the following words have the meanings indicated. 24 | |
254 | 232 | ||
255 | - | (2) | |
256 | - | ||
233 | + | (2) “Health care facility” has the same meaning stated in § 18–338.2 of this 25 | |
234 | + | subtitle. 26 | |
257 | 235 | ||
258 | - | ||
259 | - | facility | |
260 | - | ||
236 | + | (3) “Health care provider” means a physician, nurse, or designee of a health 27 | |
237 | + | care facility. 28 | |
238 | + | 6 HOUSE BILL 119 | |
261 | 239 | ||
262 | - | (2) The informed consent for HIV testing document shall be distinct and | |
263 | - | separate from all other consent forms. | |
264 | 240 | ||
265 | - | (3) A patient identifying number obtained from an anonymous and | |
266 | - | confidential test site which is approved by the Department may be evidence of a patient’s | |
267 | - | informed consent in lieu of a patient’s signature. | |
241 | + | (4) “HIV” means the human immunodeficiency virus that causes acquired 1 | |
242 | + | immune deficiency syndrome. 2 | |
268 | 243 | ||
269 | - | [(d)] (E) An individual’s refusal to undergo an HIV test or a positive test result | |
270 | - | may not be used as the sole basis by an institution or laboratory to deny services or | |
271 | - | treatment. | |
244 | + | (b) (1) Except as provided in Title 11, Subtitle 1, Part II of the Criminal 3 | |
245 | + | Procedure Article or § 18–338.3 of this subtitle, before obtaining a fluid or tissue sample 4 | |
246 | + | from the body of an individual for the purpose of testing the fluid or tissue for the presence 5 | |
247 | + | of HIV infection, a health care provider shall: 6 | |
272 | 248 | ||
273 | - | [(e)] (F) If the individual is unable to give informed consent, substitute consent | |
274 | - | may be given under § 5–605 of this article. | |
249 | + | (i) Inform the individual verbally or in writing that HIV testing will 7 | |
250 | + | be performed on a specimen obtained from the individual unless the individual refuses HIV 8 | |
251 | + | testing; 9 | |
275 | 252 | ||
276 | - | [(f)] (G) A health care provider who obtains a result from an HIV test conducted | |
277 | - | in accordance with the provisions of subsection (b) of this section shall: | |
253 | + | (ii) Provide the individual verbal or written information or show a 10 | |
254 | + | video that includes an explanation of HIV infection and the meaning of positive and 11 | |
255 | + | negative test results; 12 | |
278 | 256 | ||
279 | - | ( | |
280 | - | ||
257 | + | (iii) Offer the individual an opportunity to ask questions and decline 13 | |
258 | + | HIV testing; and 14 | |
281 | 259 | ||
282 | - | (2) If the test is positive: | |
260 | + | (iv) If the individual refuses HIV testing, document in the medical 15 | |
261 | + | record the individual’s decision. 16 | |
283 | 262 | ||
284 | - | (i) Provide a referral for treatment and supportive services; WES MOORE, Governor Ch. 752 | |
263 | + | (2) (i) Consent for HIV testing shall be included in a patient’s general 17 | |
264 | + | informed consent for medical care in the same category as other screening and diagnostic 18 | |
265 | + | tests. 19 | |
285 | 266 | ||
286 | - | – 7 – | |
267 | + | (ii) Except as otherwise provided in this section, a health care 20 | |
268 | + | provider may not be required to obtain consent for HIV testing using a separate consent 21 | |
269 | + | form. 22 | |
287 | 270 | ||
288 | - | (ii) Counsel the individual to inform all sexual and needle–sharing | |
289 | - | partners of the individual’s positive HIV status; | |
271 | + | (3) A health care provider shall make available to individuals for whom 23 | |
272 | + | HIV testing is performed easily understood informational materials in the languages of the 24 | |
273 | + | commonly encountered populations of the health care provider. 25 | |
290 | 274 | ||
291 | - | (iii) Offer to assist in notifying the individual’s sexual and | |
292 | - | needle–sharing partners or refer the individual to the local health officer to assist the | |
293 | - | individual with notifying the individual’s sexual and needle–sharing partners; and | |
275 | + | (C) UNLESS A PATIENT DECL INES SUBJECT TO SUBSECTION (B) OF THIS 26 | |
276 | + | SECTION, A HEALTH CARE PROVID ER SHALL OBTAIN A FL UID OR TISSUE SAMPLE 27 | |
277 | + | FOR THE PURPOSE OF T ESTING THE FLUID OR TISSUE FOR THE PRESE NCE OF HIV 28 | |
278 | + | INFECTION FROM : 29 | |
294 | 279 | ||
295 | - | (iv) If necessary, take action appropriate to comply with § 18–337 of | |
296 | - | this subtitle. | |
280 | + | (1) THE BODY OF A A PREGNANT WOMAN DURIN G DELIVERY; AND 30 | |
297 | 281 | ||
298 | - | ||
299 | - | ||
300 | - | ||
282 | + | (2) A NEWBORN WHEN THE PRE GNANT WOMAN ’S HIV STATUS IS 31 | |
283 | + | UNKNOWN. 32 | |
284 | + | HOUSE BILL 119 7 | |
301 | 285 | ||
302 | - | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect | |
303 | - | October 1, 2024. | |
304 | 286 | ||
305 | - | Approved by the Governor, May 16, 2024. | |
287 | + | [(c)] (D) (1) If the HIV test is ordered at a location that is not a health care 1 | |
288 | + | facility, informed consent shall be in writing and signed by the individual on an informed 2 | |
289 | + | consent for HIV testing document that is approved by the Department. 3 | |
290 | + | ||
291 | + | (2) The informed consent for HIV testing document shall be distinct and 4 | |
292 | + | separate from all other consent forms. 5 | |
293 | + | ||
294 | + | (3) A patient identifying number obtained from an anonymous and 6 | |
295 | + | confidential test site which is approved by the Department may be evidence of a patient’s 7 | |
296 | + | informed consent in lieu of a patient’s signature. 8 | |
297 | + | ||
298 | + | [(d)] (E) An individual’s refusal to undergo an HIV test or a positive test result 9 | |
299 | + | may not be used as the sole basis by an institution or laboratory to deny services or 10 | |
300 | + | treatment. 11 | |
301 | + | ||
302 | + | [(e)] (F) If the individual is unable to give informed consent, substitute consent 12 | |
303 | + | may be given under § 5–605 of this article. 13 | |
304 | + | ||
305 | + | [(f)] (G) A health care provider who obtains a result from an HIV test conducted 14 | |
306 | + | in accordance with the provisions of subsection (b) of this section shall: 15 | |
307 | + | ||
308 | + | (1) Notify the individual from whom the fluid or tissue sample was 16 | |
309 | + | obtained of the result; and 17 | |
310 | + | ||
311 | + | (2) If the test is positive: 18 | |
312 | + | ||
313 | + | (i) Provide a referral for treatment and supportive services; 19 | |
314 | + | ||
315 | + | (ii) Counsel the individual to inform all sexual and needle–sharing 20 | |
316 | + | partners of the individual’s positive HIV status; 21 | |
317 | + | ||
318 | + | (iii) Offer to assist in notifying the individual’s sexual and 22 | |
319 | + | needle–sharing partners or refer the individual to the local health officer to assist the 23 | |
320 | + | individual with notifying the individual’s sexual and needle–sharing partners; and 24 | |
321 | + | ||
322 | + | (iv) If necessary, take action appropriate to comply with § 18–337 of 25 | |
323 | + | this subtitle. 26 | |
324 | + | ||
325 | + | [(g)] (H) Local health officers shall make available to health care providers in 27 | |
326 | + | their jurisdiction information on referral resources for an individual with an HIV positive 28 | |
327 | + | status, including counseling, testing, needs assessment, treatment, and support services. 29 | |
328 | + | ||
329 | + | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 30 | |
330 | + | October 1, 2024. 31 |